Willow vs He & She MD: Oral GLP-1 plus tracking vs bundled coaching
Quick verdict: Willow focuses on a telehealth-first oral GLP-1 program with progress tracking and follow-up consultations, while He & She MD bundles compounded GLP-1 medications with a coaching app and 1:1 clinician messaging; He & She MD advertises semaglutide starting at $139/month as an intro price. The comparison below highlights differences in pricing structure, clinical support, medication formats, regulatory notes, and program framing for Willow vs He & She MD.
Explore Willow program details
Direct comparison: pricing and billing
Price is a clear early difference for Willow vs He & She MD. Willow lists a starting price of 299. He & She MD advertises compounded semaglutide injections starting at 139/month and oral semaglutide or tirzepatide from 199/month as six-month introductory rates that renew higher.
Support model and app features
Both providers emphasize support, but they position it differently. Willow frames its offering as a structured weight management journey with progress tracking tools and follow-up consultations delivered by a licensed telehealth team. He & She MD bundles a coaching app with 1:1 clinician messaging, GLP-1-specific coaching and built-in progress tracking at no extra cost.
Medication formats and program framing
Willow highlights an oral GLP-1 program with follow-up. He & She MD lists multiple formats: semaglutide injection, oral semaglutide, and tirzepatide injection, presenting medication plus coaching in a GLP-1 Platinum Program style.
Regulatory notes and compounded medications
Both sources note regulatory cautions. Willow notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. He & She MD states medications included in the GLP-1 Program are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA for safety, efficacy, or quality.
Five key differences at a glance
| Criteria | Willow | He & She MD |
|---|---|---|
| Starting price | $299 starting | Semaglutide injections from $139/mo intro; oral and tirzepatide from $199/mo intro |
| Support model | Licensed telehealth team, follow-up consultations, progress tracking | Coaching app with 1:1 clinician messaging and GLP-1 coaching included |
| Medication formats | Oral GLP-1 program emphasized | Injection and oral options: semaglutide and tirzepatide |
| Pricing structure | Listed starting price; captured page had limited readable landing evidence | Six-month introductory rates that renew higher; promo pricing limited time |
| Regulatory note | Compounded meds not FDA-approved when offered | Medications produced in USP-compliant pharmacies but not reviewed by FDA |
What each provider emphasizes in practice
Willow emphasizes converting GLP-1 efficacy into long term outcomes through structured support, describing its program as a weight management journey rather than a medication subscription. He & She MD emphasizes a bundled approach that pairs compounded GLP-1 medication with an app that includes clinician messaging and coaching, noting introductory pricing for the first six months and free expedited shipping with no membership fee.
See He & She MD intro pricing and plans
Pros and cons summary side by side
Willow pros: licensed telehealth team, progress tracking tools, follow-up consultations; con: higher monthly entry pricing for some plans. He & She MD pros: coaching app with 1:1 messaging and tracking included, multiple medication formats, competitive intro price; cons: headline prices are six-month intro rates that renew 30 to 45 percent higher and pricing is structured as six-month terms.
Primary keyword mention and closing comparison
When weighing Willow vs He & She MD, choose based on whether you prioritize an oral, telehealth-first program with structured follow-up or a bundled medication plus coaching app with lower introductory pricing and multiple medication formats.
Review Willow’s telehealth program
Choose Willow if…
…you want a telehealth-first oral GLP-1 program framed as a structured weight management journey with licensed clinician follow-up, progress tracking tools, and follow-up consultations. Treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose He & She MD if…
…you want bundled coaching and clinician access built into a plan, need multiple medication formats including injections and oral GLP-1, and are attracted to six-month introductory pricing such as semaglutide from $139/month with the understanding these rates renew higher. He & She MD includes 1:1 clinician messaging, GLP-1 coaching, progress tracking, free expedited shipping, and states medications are produced in USP-compliant, state-regulated pharmacies but are not reviewed by the FDA for safety, efficacy, or quality.